Ambev S.A. (NYSE:ABEV)’s traded shares stood at 5.11 million during the latest session, with the company’s beta value hitting 1.06. At the last check today, the stock’s price was $2.67, to imply a decrease of -1.29% or -$0.04 in intraday trading. The ABEV share’s 52-week high remains $3.32, putting it -24.34% down since that peak but still an impressive 10.11% since price per share fell to its 52-week low of $2.40. The company has a valuation of $43.57B, with an average of 21.56 million shares in intraday trading volume over the past 10 days and average of 24.74 million shares over the past 3 months.

Ambev S.A. (NYSE:ABEV) trade information

After registering a -1.29% downside in the latest session, Ambev S.A. (ABEV) has traded red over the past five days. The stock hit a weekly high of 2.72 this Thursday, 03/16/23, dropping -1.29% in its intraday price action. The 5-day price performance for the stock is 3.68%, and 6.15% over 30 days. With these gigs, the year-to-date price performance is -1.65%. Short interest in Ambev S.A. (NYSE:ABEV) saw shorts transact 20.95 million shares and set a 0.81 days time to cover.

Ambev S.A. (ABEV) estimates and forecasts

Looking at statistics comparing Ambev S.A. share performance against respective industry, we note that the company has underperformed competitors. Ambev S.A. (ABEV) shares are -6.79% down over the last 6 months, with its year-to-date growth rate lower than industry average at -5.56% against 11.30%. Revenue is forecast to shrink -25.00% this quarter before falling -25.00% for the next one. The rating firms project that company’s revenue will grow 16.60% compared to the previous financial year.

Revenue forecast for the current quarter as set by 3 analysts is $4.65 billion. Meanwhile, for the quarter ending Mar 2023, a total of 2 analyst(s) estimate revenue growth to $3.81 billion.Earnings reports from the last fiscal year show that sales brought in $3.94 billion and $3.53 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 17.90% before jumping 7.70% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 14.70% for the past 5-year period. While 2023 is set for a 14.20% return in earnings, projections for the next 5 years are at 9.40% annually.

ABEV Dividends

Ambev S.A. has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ambev S.A. has a forward dividend ratio of 0.25, with the share yield ticking at 9.26% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Ambev S.A. (NYSE:ABEV)’s Major holders

Ambev S.A. insiders hold 0.00% of total outstanding shares, with institutional holders owning 18.59% of the shares at 18.59% float percentage. In total, 18.59% institutions holds shares in the company, led by First Eagle Investment Management, LLC. As of Sep 29, 2022, the company held over 282.31 million shares (or 1.79% of shares), all amounting to roughly $798.94 million.

The next major institution holding the largest number of shares is Harding Loevner LLC with 129.46 million shares, or about 0.82% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $366.36 million.

We also have First Eagle Global Fund and First Eagle Overseas Fund as the top two Mutual Funds with the largest holdings of the Ambev S.A. (ABEV) shares. Going by data provided on Oct 30, 2022, First Eagle Global Fund holds roughly 135.88 million shares. This is just over 0.86% of the total shares, with a market valuation of $413.08 million. Data from the same date shows that the other fund manager holds a little less at 72.45 million, or 0.46% of the shares, all valued at about 220.24 million.